🔍
Search Results - ping+wu
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
PSMA-retargeted adenovirus
C11155: Method of developing targeted therapeutic agents for cancer using adenovirusValue Proposition: • Addresses a major patient need. • Specific for the target. • Enhances adenoviral gene therapy. • Has therapeutic and diagnostic applications. Technical Details: JHU scientists have developed a successful strategy to optimize targeted...
Published: 3/13/2025
|
Inventor(s):
Ping Wu
,
Ronald Rodriguez
,
Shawn Lupold
Keywords(s):
Antigens
,
Biologics
,
Cancers
,
Disease Indication
,
Drug Delivery Vehicle
,
Plasmid/Vector
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities > Biologics
,
Technology Classifications > Therapeutic Modalities > Gene Therapies
,
Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum